| Mmc Family Medical Center Llc | |
|
Carr 687 Km 0.1 Bo. Algarrobo Vega Baja PR 00693-0000 | |
| (787) 621-3724 | |
| (787) 621-3715 |
| Full Name | Mmc Family Medical Center Llc |
|---|---|
| Speciality | Clinic/Center |
| Location | Carr 687 Km 0.1, Vega Baja, Puerto Rico |
| Authorized Official Name and Position | Noriselle Rivera (VP FINANCE) |
| Authorized Official Contact | 7876213724 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Mmc Family Medical Center Llc 100 Carr 165 Tower 1 Suite 508 Guaynabo PR 00968-8052 Ph: (787) 621-3724 | Mmc Family Medical Center Llc Carr 687 Km 0.1 Bo. Algarrobo Vega Baja PR 00693-0000 Ph: (787) 621-3724 |
| NPI Number | 1285008797 |
|---|---|
| Provider Enumeration Date | 11/20/2015 |
| Last Update Date | 11/20/2015 |
| Medicare PECOS PAC ID | 0547564403 |
|---|---|
| Medicare Enrollment ID | O20160212001775 |
News Archive
The TB Alliance on Monday announced it has launched a Phase II clinical trial "of a new treatment regimen for tuberculosis, including for patients with resistance to existing multi-drug programs," Agence France-Presse reports.
Although the cause of Parkinson's disease remains a mystery, scientists now have a better understanding of the earliest stages of abnormal aggregation of a key disease-associated protein. The research, published by Cell Press online on April 6th in Biophysical Journal, provides new insight into the first steps in the formation of neurotoxic structures called Lewy bodies that are the hallmark of the Parkinson's brain.
The U.S. Food and Drug Administration today approved Incivek treat certain adults with chronic hepatitis C infection. Incivek is used for patients who have either not received interferon-based drug therapy for their infection or who have not responded adequately to prior therapies. Incivek is approved for use with interferon therapy made up of peginterferon alfa and ribavirin.
Summer Blast, held July 9, addressed a key challenge — getting minorities to seek treatment for mental illness. So important is the issue that in 2008 the U.S. House of Representatives designated July as National Minority Mental Health Month, thanks in part to the efforts of author Bebe Moore Campbell, an advocate for greater mental health awareness among minority communities.
Researchers will for the first time be defining how every cell type within the retina responds to diabetes, in a study announced by eye research charity Fight for Sight during National Eye Health Week 2018.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285008797 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QP2300X | Clinic/center - Primary Care | (* (Not Available)) | Primary |
| Provider Name | Vielka Cintron Rivera |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1295837516 PECOS PAC ID: 6608829452 Enrollment ID: I20050222000399 |
News Archive
The TB Alliance on Monday announced it has launched a Phase II clinical trial "of a new treatment regimen for tuberculosis, including for patients with resistance to existing multi-drug programs," Agence France-Presse reports.
Although the cause of Parkinson's disease remains a mystery, scientists now have a better understanding of the earliest stages of abnormal aggregation of a key disease-associated protein. The research, published by Cell Press online on April 6th in Biophysical Journal, provides new insight into the first steps in the formation of neurotoxic structures called Lewy bodies that are the hallmark of the Parkinson's brain.
The U.S. Food and Drug Administration today approved Incivek treat certain adults with chronic hepatitis C infection. Incivek is used for patients who have either not received interferon-based drug therapy for their infection or who have not responded adequately to prior therapies. Incivek is approved for use with interferon therapy made up of peginterferon alfa and ribavirin.
Summer Blast, held July 9, addressed a key challenge — getting minorities to seek treatment for mental illness. So important is the issue that in 2008 the U.S. House of Representatives designated July as National Minority Mental Health Month, thanks in part to the efforts of author Bebe Moore Campbell, an advocate for greater mental health awareness among minority communities.
Researchers will for the first time be defining how every cell type within the retina responds to diabetes, in a study announced by eye research charity Fight for Sight during National Eye Health Week 2018.
› Verified 4 days ago
| Provider Name | Yadira Reyes Rosario |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1720295157 PECOS PAC ID: 0749205755 Enrollment ID: I20051010000256 |
News Archive
The TB Alliance on Monday announced it has launched a Phase II clinical trial "of a new treatment regimen for tuberculosis, including for patients with resistance to existing multi-drug programs," Agence France-Presse reports.
Although the cause of Parkinson's disease remains a mystery, scientists now have a better understanding of the earliest stages of abnormal aggregation of a key disease-associated protein. The research, published by Cell Press online on April 6th in Biophysical Journal, provides new insight into the first steps in the formation of neurotoxic structures called Lewy bodies that are the hallmark of the Parkinson's brain.
The U.S. Food and Drug Administration today approved Incivek treat certain adults with chronic hepatitis C infection. Incivek is used for patients who have either not received interferon-based drug therapy for their infection or who have not responded adequately to prior therapies. Incivek is approved for use with interferon therapy made up of peginterferon alfa and ribavirin.
Summer Blast, held July 9, addressed a key challenge — getting minorities to seek treatment for mental illness. So important is the issue that in 2008 the U.S. House of Representatives designated July as National Minority Mental Health Month, thanks in part to the efforts of author Bebe Moore Campbell, an advocate for greater mental health awareness among minority communities.
Researchers will for the first time be defining how every cell type within the retina responds to diabetes, in a study announced by eye research charity Fight for Sight during National Eye Health Week 2018.
› Verified 4 days ago
| Provider Name | Ignacio Acevedo Sierra |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1407942212 PECOS PAC ID: 2961400718 Enrollment ID: I20061110000217 |
News Archive
The TB Alliance on Monday announced it has launched a Phase II clinical trial "of a new treatment regimen for tuberculosis, including for patients with resistance to existing multi-drug programs," Agence France-Presse reports.
Although the cause of Parkinson's disease remains a mystery, scientists now have a better understanding of the earliest stages of abnormal aggregation of a key disease-associated protein. The research, published by Cell Press online on April 6th in Biophysical Journal, provides new insight into the first steps in the formation of neurotoxic structures called Lewy bodies that are the hallmark of the Parkinson's brain.
The U.S. Food and Drug Administration today approved Incivek treat certain adults with chronic hepatitis C infection. Incivek is used for patients who have either not received interferon-based drug therapy for their infection or who have not responded adequately to prior therapies. Incivek is approved for use with interferon therapy made up of peginterferon alfa and ribavirin.
Summer Blast, held July 9, addressed a key challenge — getting minorities to seek treatment for mental illness. So important is the issue that in 2008 the U.S. House of Representatives designated July as National Minority Mental Health Month, thanks in part to the efforts of author Bebe Moore Campbell, an advocate for greater mental health awareness among minority communities.
Researchers will for the first time be defining how every cell type within the retina responds to diabetes, in a study announced by eye research charity Fight for Sight during National Eye Health Week 2018.
› Verified 4 days ago
| Provider Name | Aracelis Nieves |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1922320217 PECOS PAC ID: 4486893955 Enrollment ID: I20130612000569 |
News Archive
The TB Alliance on Monday announced it has launched a Phase II clinical trial "of a new treatment regimen for tuberculosis, including for patients with resistance to existing multi-drug programs," Agence France-Presse reports.
Although the cause of Parkinson's disease remains a mystery, scientists now have a better understanding of the earliest stages of abnormal aggregation of a key disease-associated protein. The research, published by Cell Press online on April 6th in Biophysical Journal, provides new insight into the first steps in the formation of neurotoxic structures called Lewy bodies that are the hallmark of the Parkinson's brain.
The U.S. Food and Drug Administration today approved Incivek treat certain adults with chronic hepatitis C infection. Incivek is used for patients who have either not received interferon-based drug therapy for their infection or who have not responded adequately to prior therapies. Incivek is approved for use with interferon therapy made up of peginterferon alfa and ribavirin.
Summer Blast, held July 9, addressed a key challenge — getting minorities to seek treatment for mental illness. So important is the issue that in 2008 the U.S. House of Representatives designated July as National Minority Mental Health Month, thanks in part to the efforts of author Bebe Moore Campbell, an advocate for greater mental health awareness among minority communities.
Researchers will for the first time be defining how every cell type within the retina responds to diabetes, in a study announced by eye research charity Fight for Sight during National Eye Health Week 2018.
› Verified 4 days ago
| Provider Name | Marcos Rafael Liriano Suarez |
|---|---|
| Provider Type | Practitioner - General Practice |
| Provider Identifiers | NPI Number: 1750947248 PECOS PAC ID: 1153750179 Enrollment ID: I20200326001549 |
News Archive
The TB Alliance on Monday announced it has launched a Phase II clinical trial "of a new treatment regimen for tuberculosis, including for patients with resistance to existing multi-drug programs," Agence France-Presse reports.
Although the cause of Parkinson's disease remains a mystery, scientists now have a better understanding of the earliest stages of abnormal aggregation of a key disease-associated protein. The research, published by Cell Press online on April 6th in Biophysical Journal, provides new insight into the first steps in the formation of neurotoxic structures called Lewy bodies that are the hallmark of the Parkinson's brain.
The U.S. Food and Drug Administration today approved Incivek treat certain adults with chronic hepatitis C infection. Incivek is used for patients who have either not received interferon-based drug therapy for their infection or who have not responded adequately to prior therapies. Incivek is approved for use with interferon therapy made up of peginterferon alfa and ribavirin.
Summer Blast, held July 9, addressed a key challenge — getting minorities to seek treatment for mental illness. So important is the issue that in 2008 the U.S. House of Representatives designated July as National Minority Mental Health Month, thanks in part to the efforts of author Bebe Moore Campbell, an advocate for greater mental health awareness among minority communities.
Researchers will for the first time be defining how every cell type within the retina responds to diabetes, in a study announced by eye research charity Fight for Sight during National Eye Health Week 2018.
› Verified 4 days ago
| Provider Name | Arachristie Otero Diaz |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1548784010 PECOS PAC ID: 2163822982 Enrollment ID: I20210616001870 |
News Archive
The TB Alliance on Monday announced it has launched a Phase II clinical trial "of a new treatment regimen for tuberculosis, including for patients with resistance to existing multi-drug programs," Agence France-Presse reports.
Although the cause of Parkinson's disease remains a mystery, scientists now have a better understanding of the earliest stages of abnormal aggregation of a key disease-associated protein. The research, published by Cell Press online on April 6th in Biophysical Journal, provides new insight into the first steps in the formation of neurotoxic structures called Lewy bodies that are the hallmark of the Parkinson's brain.
The U.S. Food and Drug Administration today approved Incivek treat certain adults with chronic hepatitis C infection. Incivek is used for patients who have either not received interferon-based drug therapy for their infection or who have not responded adequately to prior therapies. Incivek is approved for use with interferon therapy made up of peginterferon alfa and ribavirin.
Summer Blast, held July 9, addressed a key challenge — getting minorities to seek treatment for mental illness. So important is the issue that in 2008 the U.S. House of Representatives designated July as National Minority Mental Health Month, thanks in part to the efforts of author Bebe Moore Campbell, an advocate for greater mental health awareness among minority communities.
Researchers will for the first time be defining how every cell type within the retina responds to diabetes, in a study announced by eye research charity Fight for Sight during National Eye Health Week 2018.
› Verified 4 days ago
News Archive
The TB Alliance on Monday announced it has launched a Phase II clinical trial "of a new treatment regimen for tuberculosis, including for patients with resistance to existing multi-drug programs," Agence France-Presse reports.
Although the cause of Parkinson's disease remains a mystery, scientists now have a better understanding of the earliest stages of abnormal aggregation of a key disease-associated protein. The research, published by Cell Press online on April 6th in Biophysical Journal, provides new insight into the first steps in the formation of neurotoxic structures called Lewy bodies that are the hallmark of the Parkinson's brain.
The U.S. Food and Drug Administration today approved Incivek treat certain adults with chronic hepatitis C infection. Incivek is used for patients who have either not received interferon-based drug therapy for their infection or who have not responded adequately to prior therapies. Incivek is approved for use with interferon therapy made up of peginterferon alfa and ribavirin.
Summer Blast, held July 9, addressed a key challenge — getting minorities to seek treatment for mental illness. So important is the issue that in 2008 the U.S. House of Representatives designated July as National Minority Mental Health Month, thanks in part to the efforts of author Bebe Moore Campbell, an advocate for greater mental health awareness among minority communities.
Researchers will for the first time be defining how every cell type within the retina responds to diabetes, in a study announced by eye research charity Fight for Sight during National Eye Health Week 2018.
› Verified 4 days ago
Centro De Vacunacion Vega Baja Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2 Ave. #107 Office, Wilma N. Vazquez, Vega Baja, PR 00693 Phone: 787-855-0031 | |
Policlinica Familiar Vega Baja Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: Avenida Trio Vegabajeno, U23 Urb El Rosario Ii, Vega Baja, PR 00693 Phone: 787-858-7073 Fax: 787-807-1090 | |
Oscorp Csp Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: Carr.687 Km.0.1, Bo. Algarrobo, Vega Baja, PR 00693 Phone: 787-855-4011 Fax: 787-855-4014 | |
Brenda Aguayo Pcp Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: #29-b Calle Betances, Vega Baja, PR 00693 Phone: 787-855-0586 | |
Policlinica Salud Del Norte Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: Carr.687 Km.0.1, Bo. Algarrobo, Vega Baja, PR 00693 Phone: 787-855-4012 Fax: 787-855-4014 | |
Ac Health Services, C.s.p. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: Villas De La Playa 174, Vega Baja, PR 00693 Phone: 787-855-8472 Fax: 787-855-8472 |